Yi-Qian Lin
Overview
Explore the profile of Yi-Qian Lin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
79
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang L, Liu W, Wu S, Zhu G, Lin Y, Braddock M, et al.
Oncotarget
. 2016 Feb;
7(12):14241-50.
PMID: 26894972
Objectives: To evaluate the association between sex-specific serum high sensitive C reactive protein (hsCRP) levels and NAFLD in a large population-based study. Results: From Q1 to Q4, the incidence ratios...
2.
Liu W, Lin S, Wang L, Fang C, Lin Y, Braddock M, et al.
Medicine (Baltimore)
. 2016 Jan;
95(4):e2596.
PMID: 26825908
Diabetic ketoacidosis (DKA) is a life-threatening acute complication of diabetes mellitus and the novel systemic inflammation marker platelet-to-lymphocyte ratio (PLR) may be associated with clinical outcome in patients with DKA....
3.
Lin Y, Wang L, Pan L, Wang H, Zhu G, Liu W, et al.
Cytotherapy
. 2015 Nov;
18(2):186-97.
PMID: 26596504
The prevalence of end-stage renal disease is emerging as a serious worldwide public health problem because of the shortage of donor organs and the need to take lifelong immunosuppressive medication...
4.
Zhu G, Shi K, Huang G, Wang L, Lin Y, Braddock M, et al.
Oncotarget
. 2015 Sep;
6(29):26757-69.
PMID: 26378046
Objectives: Therapies for treatment of patients with primary sclerosing cholangitis (PSC) include administration of ursodeoxycholic acid (UDCA) alone, or combination with metronidazole (MTZ) or mycophenolate mofetil (MMF), respectively. However, the...
5.
Lin Y, Wang L, Wang J, Pan L, Zhu G, Liu W, et al.
Expert Rev Gastroenterol Hepatol
. 2015 Jul;
9(9):1183-91.
PMID: 26220044
Techniques for producing decellularized scaffolds for use in liver tissue engineering are emerging as promising methods for tissue reconstruction. In this article, the authors present an overview of liver decellularization...
6.
Zhu G, Huang S, Huang G, Wang L, Lin Y, Wu Y, et al.
Oncotarget
. 2015 Jun;
6(27):24533-49.
PMID: 26109432
Objective: Most comprehensive treatments for PBC include UDCA, combination of methotrexate (MTX), corticosteroids (COT), colchicine (COC) or bezafibrate (BEF), cyclosporin A (CYP), D-penicillamine (DPM), methotrexate (MTX), or azathioprine (AZP). Since...
7.
Wang L, Lin Y, Wang J, Pan L, Huang K, Wan L, et al.
Cytotherapy
. 2015 May;
17(8):1015-24.
PMID: 25981396
Allogeneic transplantation is the definitive treatment for patients with end-stage liver disease but is limited by donor shortage and very high cost. Through de-cellularization and re-cellularization methods, re-engineered liver may...
8.
Wang H, Lin X, Wang L, Lin Y, Wang J, Liu W, et al.
Expert Rev Neurother
. 2015 Mar;
15(5):493-500.
PMID: 25817399
Decellularization methodologies have been successfully used in a variety of tissue engineering and regenerative technologies and methods of decellularization have been developed for target tissues and organs of interest. The...
9.
Zhu G, Shi K, Huang S, Huang G, Lin Y, Zhou Z, et al.
Medicine (Baltimore)
. 2015 Mar;
94(11):e609.
PMID: 25789951
Major ursodeoxycholic acid (UDCA)-based therapies for primary biliary cirrhosis (PBC) include UDCA only, or combined with either methotrexate (MTX), corticosteroids (COT), colchicine (COC), or bezafibrate (BEF). As the optimum treatment...
10.
Targeting fibroblast growth factor 19 in liver disease: a potential biomarker and therapeutic target
Liu W, Xie D, Zhu G, Huang G, Lin Y, Wang L, et al.
Expert Opin Ther Targets
. 2014 Dec;
19(5):675-85.
PMID: 25547779
Introduction: Fibroblast growth factor 19 (FGF19) is a member of the hormone-like FGF family and has activity as an ileum-derived postprandial hormone. It shares high binding affinity with β-Klotho and...